company logo
Transforming the lives of patients with life-limiting diseases of the nervous system.
Basic Information
Engrail Therapeutics is a clinical-stage pharmaceutical company founded in 2019 with the aspiration of becoming a leader in neuroscience. We are committed to rapidly advancing our innovative, precision-targeted therapeutics.
Legal Name
:
Engrail Therapeutics, Inc.
Headquarters
:
San Diego, California, United States of America
Business Model
:
B2B  
Founding Date
:
2019
No. of Employees
:
21 to 40
Core Team
:
1.  
Vikram Sudarsan
President and CEO
2.  
Stephen Cunningham
Co-Founder and Chief Development Officer
Funding

Total Funding

$221.0M

Investors
:
1.  
Nan Fung Life Sciences
2.  
Forbion Capital Partners
3.  
F-Prime Capital
4.  
Norwest Venture Partners

See More